Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS??? EQUITY (DEFICIT) (Details Narrative)

v3.25.2
STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 28, 2025
Mar. 31, 2025
Sep. 30, 2024
Apr. 18, 2024
Mar. 28, 2024
Mar. 06, 2023
Nov. 30, 2023
Jun. 30, 2022
May 31, 2022
Sep. 30, 2021
Jun. 30, 2025
Jun. 30, 2024
Sep. 10, 2025
Sep. 09, 2025
Aug. 29, 2025
Nov. 02, 2023
Apr. 29, 2021
Common stock, share authorized 30,000,000                   75,000,000 30,000,000          
Preferred Stock, Shares Authorized                     500,000 500,000          
Preferred Stock, Par or Stated Value Per Share                     $ 0.001 $ 0.001          
Number of common stock available for grant                     252,120            
Intrinsic value of the outstanding options                                
Weighted-average remaining recognition period                     7 years 1 month 6 days 7 years 11 months 15 days          
Share-Based Payment Arrangement, Option [Member]                                  
Unamortized stock-based compensation expense                     $ 729,000            
Weighted-average remaining recognition period                     1 year 1 month 6 days            
Restricted Stock Units (RSUs) [Member]                                  
Unamortized stock-based compensation expense                     $ 312,000            
Weighted-average remaining recognition period                     10 months 24 days            
2014 Equity Incentive Plan [Member]                                  
Number of common stock available for grant                     0            
2021 Equity Incentive Plan [Member]                                  
Number of common stock available for grant                     1,133,892            
2021 Equity Incentive Plan [Member] | Maximum [Member]                                  
Number of authorized issuance of common stock options                                 2,000,000
2025 Equity Incentive Plan [Member]                                  
Number of common stock available for grant                     1,000,000            
2025 Equity Incentive Plan [Member] | Maximum [Member]                                  
Number of authorized issuance of common stock options 1,000,000                                
2014 Plan [Member] | Time-based RSU [Member]                                  
Restricted stock award granted       68,228                          
2021 Plan [Member] | Time-based RSU [Member]                                  
Restricted stock award granted 200,000                                
Employee Stock Purchase Plan [Member]                                  
Grant of options, shares           350,000                      
Employee stock purchase plan, description           (i) has been employed by the Company or a Participating Subsidiary for at least 90 days and (ii) is customarily employed for at least twenty (20) hours per week and more than five (5) months in any calendar year. Each eligible employee may authorize payroll deductions of one to 15% of the eligible employee’s compensation on each pay day to be used to purchase up to 1,500 shares of common stock for the employee’s account occurring during an offering period. The 2023 ESPP has a term of ten (10) years commencing on April 20, 2023, the date of approval by the Company’s stockholders, unless otherwise earlier terminated.                      
Number of common stock purchased   29,350 20,987   37,543                        
Common stock purchased price per share   $ 1.46 $ 2.58   $ 2.80                        
2023 Subordinated LOC [Member]                                  
Warrants term             5 years                 5 years  
Purchase of common stock, shares             41,196                 41,196  
Exercise price per share             $ 3.24                 $ 3.24  
Fair Value adjustment of warrants             $ 92,000                    
Lenders [Member]                                  
Warrants term                 5 years                
Purchase of common stock, shares               40,806 128,000                
Exercise price per share               $ 2.23 $ 2.53                
Fair Value adjustment of warrants               $ 80,000 $ 173,000                
Investors [Member]                                  
Warrants term                   5 years              
Purchase of common stock, shares                   1,071,430              
Exercise price per share                   $ 7.00              
Fair Value adjustment of warrants                   $ 3,874,000              
Beneficial ownership percentage                   4.99%              
Subsequent Event [Member]                                  
Preferred Stock, Shares Authorized                         3,000,000 500,000 3,000,000    
Preferred Stock, Par or Stated Value Per Share                         $ 0.001   $ 0.001